129 related articles for article (PubMed ID: 31924428)
21. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
Gupta M; Prinja S; Kumar R; Kaur M
Health Policy Plan; 2013 Jan; 28(1):51-61. PubMed ID: 22407018
[TBL] [Abstract][Full Text] [Related]
24. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
[TBL] [Abstract][Full Text] [Related]
25. Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform.
Verguet S; Jassat W; Bertram MY; Tollman SM; Murray CJ; Jamison DT; Hofman KJ
Glob Health Action; 2013 Mar; 6():1-9. PubMed ID: 23458088
[TBL] [Abstract][Full Text] [Related]
26. The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: A modeling study.
Lee EC; Azman AS; Kaminsky J; Moore SM; McKay HS; Lessler J
PLoS Med; 2019 Dec; 16(12):e1003003. PubMed ID: 31825965
[TBL] [Abstract][Full Text] [Related]
27. Breastfeeding promotion and priority setting in health.
Horton S; Sanghvi T; Phillips M; Fiedler J; Perez-Escamilla R; Lutter C; Rivera A; Segall-Correa AM
Health Policy Plan; 1996 Jun; 11(2):156-68. PubMed ID: 10158457
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria.
Habib AG; Lamorde M; Dalhat MM; Habib ZG; Kuznik A
PLoS Negl Trop Dis; 2015 Jan; 9(1):e3381. PubMed ID: 25569252
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage.
Ekwunife OI; Lhachimi SK
BMC Health Serv Res; 2017 Dec; 17(1):815. PubMed ID: 29216880
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia.
Tembo T; Simuyandi M; Chiyenu K; Sharma A; Chilyabanyama ON; Mbwili-Muleya C; Mazaba ML; Chilengi R
PLoS One; 2019; 14(5):e0215972. PubMed ID: 31150406
[TBL] [Abstract][Full Text] [Related]
31. Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme.
Moura Silveira M; McBride AJA; Trotter CL
Vaccine; 2019 Oct; 37(45):6783-6786. PubMed ID: 31570182
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil.
Sartori AMC; de Soárez PC; Fernandes EG; Gryninger LCF; Viscondi JYK; Novaes HMD
Vaccine; 2016 Mar; 34(13):1531-1539. PubMed ID: 26899375
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy.
Giorgi-Rossi P; Merito M; Borgia P
Health Policy; 2009 Feb; 89(2):225-38. PubMed ID: 18639952
[TBL] [Abstract][Full Text] [Related]
34. A qualitative study of the development and utilization of health facility-based immunization microplans in Uganda.
Mafigiri DK; Iradukunda C; Atumanya C; Odie M; Mancuso A; Tran N; McGrath J; Luzze H
Health Res Policy Syst; 2021 Aug; 19(Suppl 2):52. PubMed ID: 34380523
[TBL] [Abstract][Full Text] [Related]
35. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
Monath TP; Nasidi A
Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
[TBL] [Abstract][Full Text] [Related]
36. Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study.
Gargano LM; Tate JE; Parashar UD; Omer SB; Cookson ST
Confl Health; 2015; 9():5. PubMed ID: 25691915
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh.
Mahumud RA; Gow J; Alam K; Keramat SA; Hossain MG; Sultana M; Sarker AR; Islam SMS
Vaccine; 2020 Jan; 38(2):165-172. PubMed ID: 31668820
[TBL] [Abstract][Full Text] [Related]
38. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country.
Burger EA; Campos NG; Sy S; Regan C; Kim JJ
Vaccine; 2018 Aug; 36(32 Pt A):4823-4829. PubMed ID: 29807710
[TBL] [Abstract][Full Text] [Related]
39. Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan.
Griffiths UK; Wolfson LJ; Quddus A; Younus M; Hafiz RA
Bull World Health Organ; 2004 Sep; 82(9):643-51. PubMed ID: 15628201
[TBL] [Abstract][Full Text] [Related]
40. Family Health Days program contributions in vaccination of unreached and under-immunized children during routine vaccinations in Uganda.
Mupere E; Babikako HM; Okaba-Kayom V; Mutyaba RB; Mwisaka MN; Tenywa E; Lule A; Aceng JR; Mpanga-Kaggwa F; Matseketse D; Aga E
PLoS One; 2020; 15(1):e0218239. PubMed ID: 31951608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
